The 2018 AMR Benchmark compares what 30 pharmaceutical companies are doing to help bring antimicrobial resistance under control. Its assessment is based on a framework of 17 metrics across three Research Areas. Here you find the four key findings from 2018 as well as analyses of the companies' antimicrobial portfolios.

Learn more

View our detailed overview of each company’s performance